Skip to main content
. 2025 Feb 4;111(3):2535–2545. doi: 10.1097/JS9.0000000000002233

Table 4.

Secondary ClinROs based on the number of patients

Secondary ClinROs (ITT analysis) Percutaneous EVAR (n = 62) Cutdown EVAR (n = 58) P Median differences or ORs (95% CI)
Access technique success, n (%) 60 (96.8) 57 (98.3) 1.000 NA
Use of extra ProGlide device 13 (21.0) NA
 1 10 (16.1) NA
 2 2 (3.2) NA
 3 1 (1.6) NA
Duration of surgery, minutes 90 (64–120) 157 (133–208) <0.001 70 (53–88)
Length of hospital stay, days 11 (8–13) 12 (10–16) 0.016 2 (0–3)
Length of postoperative hospital stay, days 4 (3–6) 5 (3–7) 0.059 1 (0–1)
30-day overall complications, n (%) 8 (12.9) 7 (12.1) 0.890 1.079 (0.365–3.192)
30-day mortality, n (%) 1 (1.6) 3 (5.2) 0.564 0.301 (0.030–2.975)
Secondary ClinROs (PP analysis) Percutaneous EVAR (n = 60) Cutdown EVAR (n = 60) P Median differences or ORs (95% CI)
Access technique success, n (%) 60 (100) 59 (98.3) 1.000 NA
Use of extra ProGlide device 11 (18.3) NA
 1 9 (15.0) NA
 2 2 (3.3) NA
 3 0 NA
Duration of surgery, minutes 90 (64–120) 157 (133–208) <0.001 70.5 (54–88)
Length of hospital stay, days 11 (8–13) 12 (10–16) 0.040 2 (0–3)
Length of postoperative hospital stay, days 4 (3–6) 5 (3–7) 0.165 0 (0–1)
30-day overall complications, n (%) 7 (11.7) 8 (13.3) 0.783 0.858 (0.290–2.538)
30-day mortality, n (%) 1 (1.7) 3 (5.0) 0.611 0.322 (0.033–3.187)

ClinROs, clinician-reported outcomes; ITT, intention-to-treat; EVAR, endovascular abdominal aortic repair; OR, odds ratio; CI, confidence interval; PP, per-protocol.